*References:
(1) Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential,
clinical presentations, and antibiotic resistance. J Korean Med Sci. 2013 Jan;28(1):4-15.
(3) Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H, Black RE. Global burden
of childhood pneumonia and diarrhoea. Lancet. 2013 Apr 20;381(9875):1405-1416.
(6) Hamborsky J, Kroger A, Wolfe S, et al. eds. Epidemiology and Prevention of Vaccine-Preventable Diseases, Pneumococcal Disease, Chapter 17, Page 234.
(10) Mangen MJ, Huijts SM, Bonten MJ, de Wit GA. The impact of community-acquired pneumonia
on the health-related quality-of-life in elderly. BMC Infect Dis. 2017 Mar 14;17(1):208.
(11) Glick HA, Miyazaki T, Hirano K, Gonzalez E, Jodar L, Gessner BD, Isturiz RE, Arguedas A, Kohno S, Suaya JA. One-Year Quality of Life Post-Pneumonia
Diagnosis in Japanese Adults. Clin Infect Dis. 2021 Jul 15;73(2):283-290
(12) Weycker, D., Farkouh, R.A., Strutton, D.R. et al. Rates and costs of invasive pneumococcal disease
and pneumonia in persons with underlying medical conditions. BMC Health Serv Res 16, 182 (2016).
These educational documents are compiled, approved, printed and executed by Viet Nam Association of Preventive Medicine.
accompanies Viet Nam Association of Preventive Medicine to raise knowledge of public health.
Kindly consult doctors for more detailed information.
PP-PRV-VNM-0171